Unclaimed brand
Ensysce Biosciences, Inc. (NASDAQ: ENSC) is a clinical-stage biotech company developing a new class of prescription drugs that will provide patients and prescribers safer options for the use of potent prescription drugs, reducing abuse and preventing overdoses.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#2D4A77
Astronaut
45, 74, 119
216, 45, 32
62, 38, 0, 53
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#33A7B5
Pelorous
51, 167, 181
186, 56, 45
72, 8, 0, 29
Ensysce Biosciences is a leading biotech company that is dedicated to combatting the prescription drug abuse epidemic. They have developed innovative technologies that aim to improve patient care for those suffering from severe pain, while also reducing the societal and economic costs associated with drug abuse. Their groundbreaking platform, TAAP™, is a highly novel technology that effectively prevents drug abuse by reducing the possibility of snorting, extracting, injection, or chewing.
Ensysce Biosciences also offers the unique Multi-Pill Abuse Resistant technology, MPAR™, which provides an additional layer of protection to prevent drug overdose. With a focus on long-term opportunities and investment, Ensysce Biosciences is committed to creating transformative therapies to address the toughest diseases and reduce suffering using advanced technologies. Their team of brilliant minds, including experienced executives and scientists with a proven track record in pain medicine and drug development, is dedicated to making a difference in people's lives.
Connect with Ensysce Biosciences on social media to stay updated on their latest advancements in the field
Company type
Public Company
Year founded
2008
Company size
11-50 employees
Neuroplastogen therapeutics
Rare-pain drug development
Botanical psychedelic molecules
Serotonin receptor therapeutics
Complex pain treatment
